Stephen K. Brannan - Feb 9, 2023 Form 4 Insider Report for Karuna Therapeutics, Inc. (KRTX)

Role
Chief Medical Officer
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
Stock symbol
KRTX
Transactions as of
Feb 9, 2023
Transactions value $
-$934,600
Form type
4
Date filed
2/13/2023, 03:36 PM
Previous filing
Jan 9, 2023
Next filing
Mar 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRTX Common Stock Options Exercise $27.3K +5K +33.33% $5.45* 20K Feb 9, 2023 Direct
transaction KRTX Common Stock Sale -$962K -5K -25% $192.37 15K Feb 9, 2023 Direct F1
transaction KRTX Common Stock Award $0 +8.65K +57.67% $0.00 23.7K Feb 9, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRTX Option (right to buy) Options Exercise $0 -5K -14.42% $0.00 29.7K Feb 9, 2023 Common Stock 5K $5.45 Direct F3
transaction KRTX Option (right to buy) Award $0 +17.4K $0.00 17.4K Feb 9, 2023 Common Stock 17.4K $187.26 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 8, 2022.
F2 Comprised of restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest annually in four 25% installments commencing on February 9, 2024, subject to continued service through such dates.
F3 This option vested as to 25% of the shares on the first anniversary of the vesting commencement date of March 1, 2017, with additional vesting as to 12.5% of the shares underlying the option award at the end of each six month period thereafter.
F4 25% of this option shall vest on February 9, 2024, and the remaining 75% shall vest in twelve equal three-month installments over the following three years, subject to continued service through such dates.